Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Non-Current Assets (2020 - 2025)

Rapid Micro Biosystems' Non-Current Assets history spans 6 years, with the latest figure at $15.4 million for Q2 2025.

  • For Q2 2025, Non-Current Assets changed N/A year-over-year to $15.4 million; the TTM value through Jun 2025 reached $83.9 million, changed N/A, while the annual FY2024 figure was $17.3 million, 25.11% down from the prior year.
  • Non-Current Assets for Q2 2025 was $15.4 million at Rapid Micro Biosystems, down from $17.3 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $52.1 million in Q4 2022 and bottomed at $10.3 million in Q3 2021.
  • The 5-year median for Non-Current Assets is $23.0 million (2021), against an average of $26.8 million.
  • The largest annual shift saw Non-Current Assets soared 298.96% in 2022 before it tumbled 55.76% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $23.0 million in 2021, then soared by 125.97% to $52.1 million in 2022, then crashed by 55.76% to $23.0 million in 2023, then dropped by 25.11% to $17.3 million in 2024, then fell by 10.5% to $15.4 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Non-Current Assets are $15.4 million (Q2 2025), $17.3 million (Q4 2024), and $23.0 million (Q4 2023).